Immuron Ltd (IMRN)
2.89
+0.43
(+17.48%)
USD |
NASDAQ |
Apr 24, 16:00
2.89
0.00 (0.00%)
After-Hours: 20:00
Immuron Cash from Investing (TTM): 0.0881M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.0881M |
June 30, 2023 | -1.723M |
December 31, 2022 | -1.708M |
June 30, 2022 | 0.0085M |
December 31, 2021 | 0.0077M |
June 30, 2021 | 0.002M |
December 31, 2020 | -0.0004M |
Date | Value |
---|---|
June 30, 2020 | -0.0006M |
December 31, 2019 | -0.0018M |
June 30, 2019 | -0.0014M |
December 31, 2018 | -0.0023M |
June 30, 2018 | -0.004M |
December 31, 2017 | 0.0018M |
June 30, 2017 | 0.002M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.723M
Minimum
Jun 2023
0.0881M
Maximum
Dec 2023
-0.3328M
Average
-0.0005M
Median
Cash from Investing (TTM) Benchmarks
Mesoblast Ltd | -0.194M |
CERo Therapeutics Holdings Inc | -- |
Alterity Therapeutics Ltd | -0.0044M |
Kazia Therapeutics Ltd | 0.00 |
Immutep Ltd | -0.0131M |